137 related articles for article (PubMed ID: 18702118)
1. Developmental toxicity of artesunate in the rat: comparison to other artemisinins, comparison of embryotoxicity and kinetics by oral and intravenous routes, and relationship to maternal reticulocyte count.
Clark RL; Lerman SA; Cox EM; Gristwood WE; White TE
Birth Defects Res B Dev Reprod Toxicol; 2008 Aug; 83(4):397-406. PubMed ID: 18702118
[TBL] [Abstract][Full Text] [Related]
2. Artesunate: developmental toxicity and toxicokinetics in monkeys.
Clark RL; Arima A; Makori N; Nakata Y; Bernard F; Gristwood W; Harrell A; White TE; Wier PJ
Birth Defects Res B Dev Reprod Toxicol; 2008 Aug; 83(4):418-34. PubMed ID: 18702116
[TBL] [Abstract][Full Text] [Related]
3. Sensitive periods for developmental toxicity of orally administered artesunate in the rat.
White TE; Clark RL
Birth Defects Res B Dev Reprod Toxicol; 2008 Aug; 83(4):407-17. PubMed ID: 18615704
[TBL] [Abstract][Full Text] [Related]
4. Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester.
Clark RL
Reprod Toxicol; 2009 Nov; 28(3):285-96. PubMed ID: 19447170
[TBL] [Abstract][Full Text] [Related]
5. Embryotoxicity of artesunate in animal species related to drug tissue distribution and toxicokinetic profiles.
Li Q; Si Y; Smith KS; Zeng Q; Weina PJ
Birth Defects Res B Dev Reprod Toxicol; 2008 Aug; 83(4):435-45. PubMed ID: 18636509
[TBL] [Abstract][Full Text] [Related]
6. Artesunate and artelinic acid: association of embryotoxicity, reticulocytopenia, and delayed stimulation of hematopoiesis in pregnant rats.
Clark RL; Brannen KC; Sanders JE; Hoberman AM
Birth Defects Res B Dev Reprod Toxicol; 2011 Feb; 92(1):52-68. PubMed ID: 21312322
[TBL] [Abstract][Full Text] [Related]
7. Severe embryolethality of artesunate related to pharmacokinetics following intravenous and intramuscular doses in pregnant rats.
Li Q; Si Y; Xie L; Zhang J; Weina P
Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):385-93. PubMed ID: 19851989
[TBL] [Abstract][Full Text] [Related]
8. Localization of artesunate and its derivatives in the pregnant rat and fetus following oral administration and relationship to developmental toxicity.
Clark RL; Gristwood WE; Lewsley R; Wilson R; Harrell AW
Birth Defects Res B Dev Reprod Toxicol; 2010 Oct; 89(5):364-75. PubMed ID: 20717981
[TBL] [Abstract][Full Text] [Related]
9. Improved safety margin for embryotoxicity in rats for the new endoperoxide artefenomel (OZ439) as compared to artesunate.
Clark RL; Edwards TL; Longo M; Kinney J; Walker DK; Rhodes J; Clode SA; Rückle T; Wells T; Andenmatten N; Huber AC
Birth Defects Res; 2018 Apr; 110(7):553-578. PubMed ID: 29193867
[TBL] [Abstract][Full Text] [Related]
10. Effects of artemisinins on reticulocyte count and relationship to possible embryotoxicity in confirmed and unconfirmed malarial patients.
Clark RL
Birth Defects Res A Clin Mol Teratol; 2012 Feb; 94(2):61-75. PubMed ID: 22125126
[TBL] [Abstract][Full Text] [Related]
11. Artesunate-induced depletion of embryonic erythroblasts precedes embryolethality and teratogenicity in vivo.
White TE; Bushdid PB; Ritter S; Laffan SB; Clark RL
Birth Defects Res B Dev Reprod Toxicol; 2006 Oct; 77(5):413-29. PubMed ID: 17066416
[TBL] [Abstract][Full Text] [Related]
12. Effects of the combined artesunate and mefloquine antimalarial drugs on rat embryos.
Boareto AC; Müller JC; Lourenço EL; Lombardi N; Lourenço AC; Rabitto I; de Morais RN; Rios FS; Dalsenter PR
Hum Exp Toxicol; 2013 Sep; 32(9):930-41. PubMed ID: 23424214
[TBL] [Abstract][Full Text] [Related]
13. The multiple-dosing pharmacokinetics of artemether, artesunate, and their metabolite dihydroartemisinin in rats.
Xing J; Bai KH; Liu T; Wang RL; Zhang LF; Zhang SQ
Xenobiotica; 2011 Mar; 41(3):252-8. PubMed ID: 21175296
[TBL] [Abstract][Full Text] [Related]
14. Toxicity of the antimalarial artemisinin and its dervatives.
Efferth T; Kaina B
Crit Rev Toxicol; 2010 May; 40(5):405-21. PubMed ID: 20158370
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos.
Longo M; Zanoncelli S; Torre PD; Riflettuto M; Cocco F; Pesenti M; Giusti A; Colombo P; Brughera M; Mazué G; Navaratman V; Gomes M; Olliaro P
Reprod Toxicol; 2006 Nov; 22(4):797-810. PubMed ID: 16959470
[TBL] [Abstract][Full Text] [Related]
16. Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit.
Clark RL; White TE; A Clode S; Gaunt I; Winstanley P; Ward SA
Birth Defects Res B Dev Reprod Toxicol; 2004 Dec; 71(6):380-94. PubMed ID: 15617018
[TBL] [Abstract][Full Text] [Related]
17. Study on the developmental toxicity of combined artesunate and mefloquine antimalarial drugs on rats.
Boareto AC; Müller JC; de Araujo SL; Lourenço AC; Lourenço EL; Gomes C; Minatovicz B; Lombardi N; Paumgartten FR; Dalsenter PR
Reprod Toxicol; 2012 Dec; 34(4):658-64. PubMed ID: 23069110
[TBL] [Abstract][Full Text] [Related]
18. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration.
Morris CA; Duparc S; Borghini-Fuhrer I; Jung D; Shin CS; Fleckenstein L
Malar J; 2011 Sep; 10():263. PubMed ID: 21914160
[TBL] [Abstract][Full Text] [Related]
19. Developmental toxicity studies of lumefantrine and artemether in rats and rabbits.
Clark RL; Youreneff M; DeLise AM
Birth Defects Res B Dev Reprod Toxicol; 2016 Dec; 107(6):243-257. PubMed ID: 28032463
[TBL] [Abstract][Full Text] [Related]
20. Severe embryotoxicity of artemisinin derivatives in experimental animals, but possibly safe in pregnant women.
Li Q; Weina PJ
Molecules; 2009 Dec; 15(1):40-57. PubMed ID: 20110870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
